Plné znění - 2/2008 Sb. m. s.

Ministerstvo zahraničních xxxx xxxxxxx, že xxx 16. listopadu 2007 xxxx xxxxxxxxxx xxxxxxxxx XXXXXX, xxxxxxxxxxx Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx xxxxxx¹⁾, xxxxxxxx xxxxxxxxx xxxxxx xxxxx Přílohy I - Xxxxxxx zakázaných látek x xxxxx xxxxxxx.

Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Úmluvy xxx 1. xxxxx 2008 x tímto xxxx xxxxxxxxx x xxxxxxxx x xxx Xxxxxx xxxxxxxxx. Xxxx xxxxxx Xxxxxxx X x platnost xxxxxxxx xxxxxx Xxxxxxx X Xxxxxxxxxxx xxxxxx xxxxx xxxxxxx xx sportu xx xxxxx xxx xxx 2007, xxxxxxxxx xxx č. 59/2007 Xx. x. s.

Xxxxxxxx znění Xxxxxxx X x její xxxxxxx xx xxxxxxx xxxxxx se xxxxxxxxx xxxxxxxx.

X1. ANABOLICKÉ XXXXX

Xxxxxxxxxx látky xxxx xxxxxxxx.

1. XXXXXXXXXX XXXXXXXXXX STEROIDY (AAS):

x. Xxxxxxxx * XXX, xxxxxxxxxx:

1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3β,17β-xxxx); 1-xxxxxxxxxxxxx (5α-androst-1-en-3,17-dion); xxxxxxxxx (19-xxxxxxxxxxxxxxxx); xxxxxxxxxx; xxxxxxxx; xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx); xxxxxxx (17α-xxxxxxx-17β-xxxxxxxxxxxxxx-4-xxx[2,3-x]xxxxxxxx); xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxxxxxxxxxxxxxxxx (17α-metyl-5α-androst-2-en-17β-ol); xxxxxxxxxxx; xxxxxxxxxxxxx (19-nor-17α-pregn-4-en-17-ol); xxxxxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxxxxx[2,3-x]-xxxxxxx); gestrinon; 4-xxxxxxxxxxxxxxxxxx (4,17β-xxxxxxxxxxxxxxxx-4-xx-3-xx); kalusteron; xxxxxxxxx; xxxxxxxxxx; mesterolon; metandienon (17β-xxxxxxx-17α-xxxxxxxxxxxxx-1,4-xxxx-3-xx); xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx (2α, 17α-dimetyl-5α-androstan-3-on-17β-ol); xxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9-xxxx-3-xx); xxxxxx-1-xxxxxxxxxxx (17β-xxxxxxx-17α-xxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxxx (17β-hydroxy-17α-metylestr-4-en-3-on); xxxxxxxxxxxxxxx (17β-xxxxxxx-17α-xxxxxxxxxx-4,9,11-xxxxx-3-xx); xxxxxxxxxxxxxxxxx; xxxxxxxxx; nandrolon; 19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx); xxxxxxxxxx; xxxxxxxxxxxxxx; xxxxxxxxxxxx; oxabolon; xxxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxxx ([3,2-x]xxxxxxx-5α-xxxxxxxxxxxxxx-17β-xxxxxxxxxxxxxxxxx); xxxxxxxxx; stanozolol; xxxxxxxxx; 1-xxxxxxxxxxx (17β-xxxxxxx-5α-xxxxxxx-1-xx-3-xx); xxxxxxxxxxxxxxxxxxx (18α-xxxx-xxxxxx-4,9,11-xxxxx-17β-xx-3-xx); xxxxxxxxx x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

x. Xxxxxxxxx ** XXX:

Xxxxxxxxxxxxx (xxxxxxx-5-xx-3β,17β-xxxx), xxxxxxxxxxxxx (xxxxxxx-4-xx-3,17-xxxx), xxxxxxxxxxxxxxxxxx, prasteron (xxxxxxxxxxxxxxxxxxxxx, DHEA), testosteron x následující metabolity x xxxxxxx:

5α-xxxxxxxxx-3α,17α-xxxx xxxxxxx-5-xx-3β,17α-xxxx

5α-xxxxxxxxx-3α,17β-xxxx 4-xxxxxxxxxxxxx (xxxxxxx-4-xx-3β,17β-xxxx)

5α-xxxxxxxxx-3β,17α-xxxx 5-xxxxxxxxxxxxx (xxxxxxx-5-xx-3,17-xxxx)

5α-xxxxxxxxx-3β,17β-xxxx xxx-xxxxxxxxxxxxxxxxxx

androst-4-en-3α,17α-diol 3α-hydroxy-5αandrostan-17-on

xxxxxxx-4-xx-3α,17β-xxxx 3β-xxxxxxx-5αxxxxxxxxx-17-xx

xxxxxxx-5-xx-3β,17α-xxxx 19-xxxxxxxxxxxxxx

androst-5-en-3α,17α-diol 19-noretiocholanolon

xxxxxxx-5-xx-3α,17β-xxxx

X xxxxxxxxx, xxx xxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxxx xxxxxxxxx, xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx xxxx Xxxxxxxxx xxxxx a xxxx xxxxxx pozitivní Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxx xx koncentrace Xxxxxxxx látky xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxxx x/xxxx xxxx xx xxxxxxxx jiný xxxxxxxxx xxxxx xx Xxxxxx Sportovce xxxxxxxx xxxxxxxxx xx rozmezí xxxxxx, xxxxx xx xxxxxxxx xxxxxxxxx x xxxx tak, že xxxxxxxxxx xxxxxxxx endogenní xxxxxxxx. Xxxxxx xx xxx xx xx, xx Xxxxxx obsahuje Xxxxxxxxx látku v xxxxxxx xxxxxxx, xxxxx Xxxxxxxxx xxxxxxx, xx xx koncentrace Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx xxxx xxxxxxxxxx x/xxxx xxxxxxxxx xxxxx xx Xxxxxx Sportovce xxxxxxxx xxxxxxxxxxxxx xxxx xxxxxxxxxxxx xxxxxx.

Bude xx xxx xx xx, xx Vzorek Xxxxxxxxx obsahuje Zakázanou xxxxx x laboratoř xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx xx všech xxxxxxxxx a xxx xxxxxxxxx xxxxxxxxxxx, xxxxx xxx podle xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) prokázat, xx xx Zakázaná látka xxxxxxxxxx původu. X xxxxxxx případě xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

Xxxx xx xxxxxxx xxxxxxxx xxxxxxx xxxxxxxx neodchylují od xxxxxxx hodnot, které xx xxxxxxxx xxxxxxxxx x xxxx a xxxxx xxxxxxxxxx analytická xxxxxx (xxxx. IRMS) xxxxxxxxxxx xxxxxxxx xxxxx Xxxxxxxx xxxxx, xxx xxxxxxxx známky xxxxxxx Xxxxxxxx xxxxx, xxxx xxxx. xxxxxxxxx s xxxxxxxxxxx xxxxxxxxxxxx steroidními xxxxxxx, xxxx když xxxxxxxxx nahlásila xxxxx X/X xxxxx než xxxxx (4) ku xxxxx (1) x xxxxx xxxxxxxxxx analytická xxxxxx (např. IRMS) xxxxxxxxxxx exogenní původ xxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx xxxxx xxxxxxx xxxxxxxxxx výsledků xxxxxxxxxx xxxxx xxxx xxxxxxxxxx xxxxxxxxxx xxxxx.

Xx-xx vyžadováno xxxxxx xxxxx šetření, pak xxxxxxxx xxxx xxxxxxxxxx xxxxxx jako xxxxxxxxx x xx xxxx xxxxxxxxx. Pokud laboratoř xxxxxxx, xx xxxxxxx xxxxxxxxxx xxxxxxxxxx metody (xxxx. XXXX) exogenní xxxxx Zakázané xxxxx, xxxx xxxxx xxxxxxxx xxxxx xxxxxxx, a xxxx xx mít xx to, že Xxxxxx obsahuje Zakázanou xxxxx. Pokud xxxxxx xxxxxxx xxxxxxxxxx analytická xxxxxx (xxxx. XXXX) x xxxxxx x xxxxxxxxx xxxxxxxxx 3 xxxxxxxxx xxxxx, xxxx xxxxxxx longitudinální xxxxxx Xxxxxxxxx tím, xx xxxx xxxxxxxxxx Antidopingovou xxxxxxxxxx v xxxxxxxxxxxxx 3 xxxxxxxx xxxxxxx xxxxxxxx bez xxxxxxxxxxx xxxxxxxx. Xxxxxxxx, xxxxx xxxxxxxxxx xxxx longitudinální xxxxxx, xxxx xxxxxx xxxx neobvyklý. Xxxxx xxxxxxxxxxxxxx xxxxxx Sportovce, xxxxxxxx xxxxxxxxxx xxxxx, xxxx xxxxxxxxxxxx xxxxxxxx, xxxx xx xxx xxxxxxxxx xx Pozitivní xxxxxxxxxxx nález.

X xxxxxxxx vzácných xxxxxxxxxxxxxx xxxxxxxxx xxxx xxx x xxxx xxxxxx xxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxx xx xxxxxx xxxxxx xxxxxxxxxxxxx (ng/ml). Xxxxx xxxxxxxxx xxxxxx xxxxx xxxxxxxxx x xxxxxxx xxxxxxxxxx xxxxxxxxxx xxxxxx (xxxx. XXXX) xxxxxxxxxxx xxxxxxxx původ Xxxxxxxx xxxxx, xxxx xxx provedeno xxxxx xxxxxxx xxxxxxxxxx následného xxxxx (xxxxxxxxxx testů).

Xxxxx laboratoř xxxxxxxxx Xxxxxxxxx laboratorní xxxxx 19-xxxxxxxxxxxxxxx, xxxx xx xx xxxxxxxxx xx xxxxxxx x xxxxxxxxxxx xxxxx exogenního xxxxxx Xxxxxxxx xxxxx. X xxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx xxxxx xxxxxxx.

V xxxxxxx, xx Xxxxxxxxx xxxxxx xxxxxxxxxxxxx xxx xxxxxxx xxxxxxxxx, bude xx xxx xx xx, xx Xxxxxx Xxxxxxxxx xxxxxxxx Xxxxxxxxx xxxxx.

2. Xxxxxxx xxxxxxxxxx xxxxx, xxxxxxxxxx:

Klenbuterol, xxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (SARM), xxxxxxx, xxxxxxx, zilpaterol, xxx xx x xxxxxxxx xxxxx xx xx.

X2. XXXXXXX A XXXXXXXX XXXXX

Xxxxxxxxxxx xxxxx x jejich uvolňující xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxxxx (EPO);

2. Xxxxxxx hormon (xXX), xxxxxxxx xxxxxxx xxxxxxx xxxxxxx (např. XXX-1), xxxxxxxxxx růstové xxxxxxx (MGF);

3. Xxxxxxxxxxxxx (xxxx. XX, xXX), zakázané xxx x mužů;

4. Xxxxxxxx;

5. Xxxxxxxxxxxxxx

x xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.

Xxxxx Xxxxxxxxx nemůže xxxxxxxx, xx xxxxxxxxxxx byla xxxxxxxxx xxxxxxxxxxxxx xx xxxxxxxxxxxx xxxxxx, xxxx xx xxx xx xx, xx Xxxxxx xxxxxxxx Zakázanou xxxxx (xxx je xxxxxxx xxxx) v případech, xxx xxxxxxxxxxx Xxxxxxxx xxxxx xxxx xxxxxx xxxxxxxxxx či xxxxxxxxxx x/xxxx xxxxxxxxx poměry xx Xxxxxx Xxxxxxxxx xxxxxxx překročí xxxxxxx xxxxxxxx xxxxxxxx x xxxx tak, že xxxxxxxxxxxx normální endogenní xxxxxxxx.

Pokud laboratoř xxxxxxxxx, xx užití xxxxxxxxxx xxxxxxxxxx xxxxxx, xx Xxxxxxxx xxxxx xx exogenního původu, xxxx se xxx xx xx, xx Xxxxxx obsahuje Zakázanou xxxxx a xxxx xxxxxxx Xxxxxxxxx xxxxxxxxxxx xxxxx.

X3. XXXX-2 AGONISTÉ

Xxxxxxx xxxx-2 xxxxxxxx xxxxxx xxxxxx X- a X-xxxxxxx xxxx zakázáni.

Xxxxxxxx xxxx xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxxx, pro xxxxx xx xxx xxxxxxxx xxxxx xxxxxxx zkrácené xxxxxxxxxxxx xxxxxxx.

X xxxx xxxx xxxxxxx xxxxxxxx forma xxxxxxxxxxxx xxxxxxx, bude nález xxxxxxxxxxx (xxxxx xxxx xxxxxxxxxx) xxxxx než 1000 xxxxxxxxx x 1 mililitru moči xxxxxxxxx xx Xxxxxxxxx xxxxxxxxxxx nález, pokud Xxxxxxxxx xxxxxxxxx, že xxxxxxxxxx výsledek xxx xxxxxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxxxx v inhalaci.

S4. ANTAGONISTÉ X MODULÁTORY XXXXXXX

Xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx:

1. Xxxxxxxxxx xxxxxxxx, xxxxxxxxxx:

2. Selektivní modulátory xxxxxxxxxxxxx receptorů (SERM), xxxxxxxx:

3. Xxxxxxx xxxxxxxxxxxxxx látky xxxxxxxxxx:

4. Xxxxx modifikující xxxxxx xxxxxxxxxx včetně inhibitorů xxxxxxxxxx, ale ne x xxxxxxxx pouze xx xx.

X5. XXXXXXXXX X XXXXXXX XXXXXXXXX LÁTKY

Xxxxxxxxx xxxxx xxxx zakázané. Zahrnují:

Xxxxxxxxx*, epitestosteron, xxxxxxxxxx, xxxxxxxxxx xxxx-xxxxxxxxx (xxxx. xxxxxxxxxx, xxxxxxxxxx), xxxxxxxxxxxxxxx (xxxx. xxxxxxx, dextran, xxxxxxxxxxxxxxxxx) a xxxxx xxxxx s xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxxxxx, amilorid, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, spironolakton, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx), triamteren x xxxxx látky x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx (xxxxx xxxxxxxxxxxx, který xxxx xxxxxxxx).

* Terapeutická xxxxxxx není xxxxxx, xxxxx moč Sportovce xxxxxxxx diuretika ve xxxxxxx x xxxxxxxx xxxx xxxxxxxxxxx hladinou xxxx Zakázané xxxxx (xxxxx).

X1. XXXXXXXXX XXXXXXX XXXXXXX

Zakázané xx xxxxxxxxxxx:

X2. CHEMICKÁ X XXXXXXXXX XXXXXXXXXX

M3. XXXXXX XXXXXX

Neterapeutické xxxxxxx buněk, genů, xxxxxxxx xxxxxxxx, xxxx xxxxxxxxxx exprese xxxx, xxxxx xxxx xxxxxxxxx xxxxxx xxxxxxxxx xxxxx, xx xxxxxxxx.

X6. XXXXXXXXXXX

Xxxxxxx xxxxxxxxxxx (včetně obou xxxxxx případných optických (X- x L-) xxxxxxx) jsou xxxxxxxx, x xxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxx xxxxxx xxxxxxxx užití x stimulancií zahrnutých xx Xxxxxxxxxxxxxx programu xxx rok 2008.

Xxxxxxxxxxx zahrnují:

Xxxxxxxxx, xxxxxxxxx**, xxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxx, amfetamin, xxxxxxxxxxx, xxxxxxxxxxxxxxx, bromantan, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxxx****, xxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, famprofazon, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, fenkamfamin, fenkamin, xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxx, xxxxxxxxx, 4-xxxxxxxxxxxxxx (xxxxxxxx), xxxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxx, xxxxx***, xxxxxxxxxxx, kokain, xxxxxxxxxxx, xxxxxxxxxx, levmetamfetamin, xxxxxxxxx, mefentermin, xxxxxxxxxxxx, xxxxxxxxxxxx (X-), xxxxxxxxxxxx****, xxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxxxxxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxxxxxxxx, xxxxxxx, pentetrazol, x-xxxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx x další látky x podobnou chemickou xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx účinky.

Xxxxxxxxxxxx neuvedené xxxxxxxx xxxx xxxxxxxx x xxxxx xxxxxx bude xxxxxxxxxx xx specifickou xxxxx pouze, xxxxx Xxxxxxxxx xxxxxxx, xx xxxx všeobecná xxxxxxxxxx x běžných xxxxxxxxx xxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxxxxxxxx pravidel, xxxx xx x xxx xxxxx xxxxxxxxxxxxxxx, xx bude xxxxxxx xxxxxxxx xxxx xxxxxxxxx xxxxx.

X7. XXXXXXXXX

Následující narkotika xxxx zakázaná:

Xxxxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxx(xxxxxx), xxxxxxxx x xxxx deriváty, xxxxxxxxxxx, xxxxxxx, morfin, xxxxxxxx, xxxxxxxxx, xxxxxxxxxx, xxxxxxx.

X8. XXXXXXXXXXX

Xxxxxxxxxxx (xxxx. xxxxx, xxxxxxxxx) jsou xxxxxxxx.

S9. XXXXXXXXXXXXXXXXXXXX

Xxxxxxx glukokortikosteroidy xxxxxxxx xxxxxx, xxxxxxxx, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx jsou zakázané. Xxxxxx užití xxxxxxxx xxxxxxxxxxxxx xxxxxxx.

Xxxx xxxxxxx injekční xxxxxxxx (xxxxxxxxxxxx, xx xxxxx xxxxxx, do xxxxx xxxxxx, xxxxxxxxxx, xx xxxx) a xxxxxxxxx xxxxxxxx xxxxxxxx zkrácenou xxxxxxxxxxxxx xxxxxxx s xxxxxxxx níže uvedených.

Xxxxxxx přípravky xxxxxxxx xx xxxxxx xxxxx (xxxxxx iontoforézy/fonoforézy), xxxx, xxxxx, xxxx, potíže xxxxx řitního otvoru, xxxxxxxx xxx x xxxxx xxxxxx zakázané x xxxxxxxxxx xxxxxx xxxxx terapeutické xxxxxxx.

X1. XXXXXXX

Alkohol (xxxxxx) xx zakázaný xxxxx Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx bude xxxxxxxx xxxxxxxx xxxxxxxx x/xxxx xxxxxxxx xxxx. Xxxxxxx xxxxxxx xxx xxxxxxxx xxxxxxxxxxx xxxxxxxx (xxxxxxxxxxxxx xxxxxxx) xx xxx xxxxxx xxxxxxxx uvedena x xxxxxxxxx.

∙ Xxxxxxxxxxxx xxxxx (FIA) (0.10 x/x)

∙ Xxxxxx (XXX) (0.10 x/x)

∙ Xxxxxxx xxxxxx a xxxxxxxxxxxx (XXX) (0.20 g/l)

∙ Xxxxxxxxxxx (FITA, XXX) (0.10 x/x)

∙ Moderní xxxxxxx (XXXX) jen pro xxxxxxxxxx xx xxxxxxxx (0.10 g/l)

∙ Motocyklový xxxxx (XXX) (0.10 x/x)

∙ Vodní xxxxxxxxxx (XXX) (0.30 x/x)

∙ Xxxxxxx (IPC) (0.10 x/x)

X2. XXXX-XXXXXXXXX

Xxxxx xxxx xxxxx určeno, xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx Xxx xxxxxxx x xxxxxxxxxxxxx xxxxxxxx.

∙ Automobilový xxxxx (XXX)

∙ Billiard (XXXX)

∙ Xxxx (XXXX)

∙ Xxxxx (XXX)

∙ Curling (XXX)

∙ Gymnastika (XXX)

∙ Xxxxxxxx (XXXX) - "xxxxx xxxx" - jen xxxxxxxxxxx

∙ Xxxxxxx (XXX)

∙ Letecké xxxxxx x xxxxxxxxxxxx (XXX)

∙ Xxxxxxxxxxx (XXXX, XXX) (zakázané xxxx Mimo soutěž)

∙ Xxxxxxxx (FIS) - xxxxx xx xxxxxx a xxxxxxxxxxx xxxxxxxx-xxxxx x X-xxxxx, x xxxxxxxxx X-xxxxx x "xxx xxx"

∙ Moderní pětiboj (XXXX) - jen xxxxxxxxxx se xxxxxxxx

∙ Xxxxxxxxxxx sport (XXX)

∙ Xxxxxxxx x xxxxxxx xxxxxx (XXXX, XXX "bowls")

∙ Střelba (XXXX, XXX) (xxxxxxxx také Xxxx xxxxxx)

∙ Xxxxx xxxxxxxxxx (UIM)

∙ Xxxxx (XXXX)

Xxxx-xxxxxxxxx xxxxxxxx následující xxxxx:

Xxxxxxxxxx, xxxxxxxxxx, xxxxxxxx, betaxolol, xxxxxxxxxx, xxxxxxx, xxxxxxxxxx, xxxxxxx, xxxxxxxxx, karvedilol, labetalol, xxxxxxxxxxx, xxxxxxxxxxxx, metoprolol, xxxxxxx, xxxxxxxxxx, pindolol, xxxxxxxxxxx, xxxxxxx, xxxxxxx, xxx xx x xxxxxxxx pouze na xx

"Xxxxxxxxxx látky"* xxxx xxxxxxxxxxx níže:

∙ Všichni Beta-2 xxxxxxxx x inhalaci, xxxxx salbutamolu (xxxxxxx xxxx glukuronidu) xxx xxxxxxxx xxxxxx xxx 1000 xx/xx xxxx x xxxxxxxxxxxx (zařazen xx xxxxxxx S 1.2 Ostatní xxxxxxxxxx xxxxx);

∙ Xxxxxxxxxx xxxx-xxxxxxxxx, xxxxxxxxxx;

∙ Xxxxx, kropropamid, krotetamid, xxxxxxx, xxxxxxxx, famprofazon, xxxxxxxxxxxxx, haptaminol, xxxxxxxxxxxx, xxxxxxxxxxxxxxx, xxxxxxxxxxxx, x-xxxxxxxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, norfenefrin, xxxxxxxxx, ortetamin, xxxxxxxxx, xxxxxxxxxxxxxx, selegilin, sibutramin, xxxxxxxxxxxxx x xxxxxxx xxxxxxx xxxxxxxxxxx neuvedená xxxxxxxx v oddíle X6, pro která Xxxxxxxxx prokáže, xx xxxxxxx xxxxxxxx popsané x oddíle S6;

∙ Xxxxxxxxxxx;

∙ Xxxxxxx Xxxxxxxxxxxxxxxxxxxx;

∙ Xxxxxxx;

∙ Xxxxxxx Xxxx-xxxxxxxxx.

*"X Xxxxxxx xxxxx xxx xxxxxxxxxxx xxxxxxxxxx látky, xxxxx xxxxxxxx xxxxxxxx neúmyslné xxxxxxxx xxxxxxxxxxxxxxx pravidel, xxxxxxx xxxx xxxxxxxxx xxxxxxxx x běžných xxxxxxxxx přípravcích, xxxx x xxxxx xx xxxxx xxxxxxxxxxxxxxx, xx xxxxx úspěšně xxxxxxxx xxxx dopingová xxxxxxx." Xxxxxxxx xxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxx xxxxx xxxx xxxxxxxx xxxxxxx xxxxxx xx předpokladu, xx "...Xxxxxxxxx xxxx xxxxx xxxxxxxx, xx Xxxxxxx xxxxxxxxxx xxxxx xxxxxx zamýšleno ke xxxxxxx xxxxxxxxxxx výkonu...".

Xxxxxx xxxxxxx x. 2/2008 Xx. x. x. xxxxx účinnosti xxxx 31.1.2008.

Xxxxxx xxxxxxx č. 2/2008 Xx. m. x. xxx xxxxxx xxxxxxx xxxxxxxxx č. 8/2009 Sb. m. s. x účinností od 7.2.2009.

Znění xxxxxxxxxxxx právních xxxxx xxxxxx xxxxxxxx předpisů x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx xxxxxxxx.